Galera Therapeutics - Press Releases

Dec 12, 2022	Galera Submits New Drug Application for Avasopasem for Severe Oral Mucositis	View HTML PDF Version
Nov 22, 2022	Galera to Present at Piper Sandler Annual Healthcare Conference	View HTML PDF Version
Nov 09, 2022	Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates	View HTML PDF Version
Oct 26, 2022	Galera Announces Presentation of Phase 3 ROMAN Long-term Follow-up Data at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting	View HTML PDF Version
Sep 26, 2022	Galera to Present at 2022 American Society for Radiation Oncology (ASTRO) Annual Meeting	View HTML PDF Version
Sep 06, 2022	Galera to Participate in the H.C. Wainwright 24th Annual Global Investment Conference	View HTML PDF Version
Sep 01, 2022	Galera Appoints Eugene P. Kennedy, M.D., F.A.C.S., as Chief Medical Officer	View HTML PDF Version
Aug 09, 2022	Galera Reports Second Quarter 2022 Financial Results and Recent Corporate Updates	View HTML PDF Version
Jun 29, 2022	Galera Announces Results from Phase 1 Stage of GRECO-1 Trial of Rucosopasem with SBRT for NSCLC	View HTML PDF Version
Jun 02, 2022	Galera to Present at Jefferies Healthcare Conference	View HTML PDF Version